About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Expert Consensus

Systems mapping: a novel approach to national lung cancer screening implementation in Australia
Sandra Marjanovic, Andrew Page, Emily Stone, Danielle J. Currie, Nicole M. Rankin, Renelle Myers, Fraser Brims, Neal Navani, Kate A. McBride

Original Article

Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis
Baishen Zhang, Jing Chen, Hui Yu, Meichen Li, Likun Chen
Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review
Izabela Chmielewska, Paweł Krawczyk, Magdalena Wójcik-Superczyńska, Anna Grenda, Michał Gil, Katarzyna Stencel, Robert Kieszko, Tomasz Jankowski, Janusz Milanowski
Efficacy and safety of radial probe endobronchial ultrasound-guided biopsy for peripheral lung lesions in chronic obstructive pulmonary disease patients
Young Seok Lee, Kyung Soo Hong, Jong Geol Jang, June Hong Ahn
Detailed characterization of combination treatment with MET inhibitor plus EGFR inhibitor in EGFR-mutant and MET-amplified non-small cell lung cancer
Youngjoo Lee, Seog-Yun Park, Geon Kook Lee, Hyun-Ju Lim, Yu-Ra Choi, Jaemin Kim, Ji-Youn Han
Exposure-lag response of surface net solar radiation on lung cancer incidence: a global time-series analysis
Xuanzhuang Lu, Runchen Wang, Jianfu Li, Shixuan Lyu, Jianrong Zhang, Qixia Wang, Wenhao Chi, Ran Zhong, Chao Chen, Xinjian Wu, Ruiyu Hu, Zhixuan You, Yuqi Mai, Songlin Xie, Jiayu Lin, Boyu Zheng, Qiu Zhong, Jianxing He, Wenhua Liang
Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients
Cheng-Di Weng, Ke-Jun Liu, Shi Jin, Jun-Wei Su, Yi-Hui Yao, Cheng-Zhi Zhou, Yu-Fa Li, Ze-Xin Chen, Hua-Jun Chen, Yan-Ying Li, Ke-Jing Tang, Jin-Ji Yang
Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
Quan Zheng, Jian Zhou, Yuanjin Zhang, Tengyong Wang, Dongsheng Wu, Qiang Pu, Jiandong Mei, Hu Liao, Lunxu Liu
Electromagnetic navigation bronchoscopy-guided preoperative lung nodule localization in video-assisted thoracic surgery (VATS): a learning curve analysis
Menghua Xue, Ke Lan, Xiaolong Yan, Tao Jiang, Xiaoping Wang, Feng Tian, Yunfeng Ni, Jinbo Zhao
Impact of docetaxel plus ramucirumab therapy on interstitial lung disease in recurrent advanced non-small cell lung cancer patients
Noriyuki Ebi, Hiroyuki Inoue, Yuta Fujimoto, Maiya Chen, Rei Sanai, Natsumi Kushima, Yusuke Osaki, Takato Ikeda, Akira Nakao, Yuki Shundo, Toyoshi Yanagihara, Naoki Hamada, Masaki Fujita
Predicting prognosis in patients with stage IA lung adenocarcinoma with a micropapillary component using a nomogram based on computed tomography radiomics and clinicopathologic factors: a retrospective analysis
Ying Li, Junfeng Zhao, Ruyue Li, Xiujing Yao, Xue Dong, Ying Zhao, Zhongshuo Xia, Yali Xu, Yintao Li
Prognostic significance of bone metastasis and clinical value of bone radiotherapy in metastatic non-small cell lung cancer receiving PD-1/PD-L1 inhibitors: results from a multicenter, prospective, observational study
Huiling Dong, Aihua Lan, Jie Gao, Yulin An, Li Chu, Xi Yang, Xiao Chu, Jie Hu, Qian Chu, Jianjiao Ni, Zhengfei Zhu
A nomogram for predicting invasiveness of lung adenocarcinoma manifesting as ground-glass nodules based on follow-up CT imaging
Hanting Li, Qinyue Luo, Yuting Zheng, Chengyu Ding, Jinrong Yang, Leqing Chen, Xiaoqing Liu, Tingting Guo, Jun Fan, Xiaoyu Han, Heshui Shi
Inflammation, tertiary lymphoid structures, and lung cancer: a bibliometric analysis
Xiwen Liu, Huiting Liu, Linchong Huang, Lixuan Lin, Qi Cai, Yang Xiang, Zengfu Liu, Shuxin Zeng, Jianxing He, Wenhua Liang
Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%
Alejandro Olivares-Hernández, Luis Posado-Domínguez, Juan Carlos Redondo-González, Laura Corvo-Félix, Lorena Bellido Hernández, Emilio Fonseca-Sánchez, Edel del Barco-Morillo
SWItch/Sucrose Nonfermentable complex-deficient pulmonary neoplasms: clinicopathologic characteristics and outcomes to radiotherapy and immunotherapy
Yu Gu, Songtao Lai, Juan Yang, Junhua Zhang, Xingwen Fan, Qiang Zheng
Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study)
Shinnosuke Takemoto, Minoru Fukuda, Ryosuke Ogata, Hiroaki Senju, Nanae Sugasaki, Katsumi Nakatomi, Hiromi Tomono, Takayuki Suyama, Eisuke Sasaki, Midori Matsuo, Kazumasa Akagi, Fumiko Hayashi, Yosuke Dotsu, Sawana Ono, Noritaka Honda, Hirokazu Taniguchi, Hiroshi Gyotoku, Takaya Ikeda, Seiji Nagashima, Hiroshi Soda, Akitoshi Kinoshita, Hiroshi Mukae
Microbiota modulate immune repertories in lung adenocarcinoma via microbiota-immunity interactive network
Peng Liang, Qianxi Chen, Xiaoping Chen, Xiaolin Zhang, Yizhen Xiao, Guangni Liang, Ming Liu, Jianxing He, Wenhua Liang, Yufeng Liang, Bo Chen
Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation
Ziying Zhao, Xiaoqing Feng, Huijuan Wu, Shuisheng Chen, Changsong Ma, Ziyun Guan, Luwen Lei, Kejing Tang, Xiao Chen, Yong Dong, Yubo Tang
Necroptosis-related lncRNAs: biomarkers for predicting prognosis and immune response in lung adenocarcinoma
Chunxuan Lin, Kunpeng Lin, Xiaochun Lin, Hai Yuan, Yingying Zhang, Zhijun Xie, Yong Dai, Luhao Liu, Yoshihisa Shimada, Taichiro Goto, Katsuhiro Okuda, Taisheng Liu, Chenggong Wei
Role of CENPL, DARS2, and PAICS in determining the prognosis of patients with lung adenocarcinoma
Rongjian Xu, Fengyi Han, Yandong Zhao, Ao Liu, Ning An, Baogang Wang, Patrick Zardo, José Sanz-Santos, Aimée J. P. M. Franssen, Erik R. de Loos, Min Zhao
DeepGR: a deep-learning prognostic model based on glycolytic radiomics for non-small cell lung cancer
Tingting Fu, Peipei Yan, Lina Zhou, Zhihua Lu, Ao Liu, Xiao Ding, Jacopo Vannucci, Paul Hofman, Andrzej Swierniak, Edyta Szurowska, Junjun Zhang, Shicheng Li
The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort study
Shuai-Dong Lin, Chang-Yong Tong, Dan-Dong Huang, Antonio Rossi, Hiroyuki Adachi, Miao Miao, Wen-Xin Zheng, Jing Guo
Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients
Yang Pan, Xuanhong Jin, Jiandong Hong, Yuxia Wang, Haoting Xu, Jingwei Lin, Yan Zhang, Kailai Yin, Jinhao Zhang, Kentaro Inamura, Dujiang Liu, Feng Li, Jian Zeng
Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study
Wei-Hong Zhang, Bing-Xue Li, Chen-Xi Ma, Jian Wang, Fan Yang, Yan-Juan Xiong, Shu-Zhan Li, Jia-Li Zhang, Wei-Jiao Du, Zhen-Zhen Hui, Meng Shen, Li Zhou, Run-Mei Li, Xiao Tian, Ying Han, Bao-Zhu Ren, Yoshinobu Ichiki, Sang Chul Lee, Xin-Wei Zhang, Shui Cao, Xiu-Bao Ren, Liang Liu
Clinical, pathological, and computed tomography morphological features of lung cancer with spread through air spaces
Xiuming Zhang, Wei Qiao, Jiannan Shen, Qianlai Jiang, Chunhan Pan, Yunnong Wang, Joanna Bidzińska, Feng Dai, Lei Zhang
Review Article 
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa, Shaker A. Mousa
Published online: 30 June 2016
Review Articles 
Irreversible EGFR-TKIs: dreaming perfection
Lorenza Landi, Federico Cappuzzo
Published online: 14 January 2013
Review Article 
Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology
Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group
Published online: 28 February 2017
Review Article 
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Published online: 28 August 2014
Review Article 
The past, present and future of immunotherapy against tumor
Tao Jiang, Caicun Zhou
Published online: 24 June 2015
Review Article 
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song
Published online: 30 June 2019
Review Article 
Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights
Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi
Published online: 28 August 2018
Review Articles 
KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach
Javier de Castro Carpeño, Cristóbal Belda-Iniesta
Published online: 03 April 2013
Review Article 
Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda
Published online: 30 June 2019
Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer 
Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Published online: 11 October 2017
Review Article 
The epidemiology of lung cancer
Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden
Published online: 14 June 2018
Review Articles 
New TNM classification: achievements and hurdles
Peter Goldstraw
Published online: 17 August 2013
Consensus 
Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen
Published online: 28 August 2021
Review Article 
Lung cancer screening: nodule identification and characterization
Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser
Published online: 14 June 2018
Review Article 
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Published online: 19 April 2015
Review Articles 
Angiogenesis in cancer: anti-VEGF escape mechanisms
Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski
Published online: 18 February 2012

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis
Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song
BRAF mutations in non-small cell lung cancer
Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper
The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer
Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper
Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice
Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song
Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer
Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song
Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer
Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen
The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants
Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden
The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices
Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto
Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement
Hyojin Kim, Jin-Haeng Chung
Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu
Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review
Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao
Clinical trials for lung cancer in China
Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu
Recurrence after surgery in patients with NSCLC
Hidetaka Uramoto, Fumihiro Tanaka
Prognostic markers in lung cancer: is it ready for prime time?
Chang-Qi Zhu, Ming-Sound Tsao
Potential biomarkers for lung cancer screening
Gabriella Sozzi, Mattia Boeri
Particle therapy in non-small cell lung cancer
Zhongxing Liao, Charles B. Simone II
Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions
Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai
Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer
Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors
Suchit H. Patel, Andreas Rimner, Roger B. Cohen
Intraoperative near-infrared imaging of mesothelioma
Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal
BAP1, a tumor suppressor gene driving malignant mesothelioma
Mitchell Cheung, Joseph R. Testa
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation
Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update
Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang
Immunotherapy for malignant pleural mesothelioma: current status and future directions
Jordan Dozier, Hua Zheng, Prasad S. Adusumilli
Biology and clinical significance of circulating tumor cell subpopulations in lung cancer
Linda O’Flaherty, Harriet Wikman, Klaus Pantel
Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?
Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace
Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer
Sumitra Mohan, Francesca Chemi, Ged Brady
Biophysical technologies for understanding circulating tumor cell biology and metastasis
Derrick W. Su, Jorge Nieva
Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer
Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno
Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer
Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis
Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

Editorials

Dulanermin in cancer therapy: Still much to do
Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data
Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner
Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung
Pedro Mendez, Jose Luis Ramirez
Role of HGF/MET axis in resistance of lung cancer to contemporary management
Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr
Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review
Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack
Lorenza Landi, Federico Cappuzzo

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung
Yoon Jin Cha, Hyo Sup Shim
Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.